$3.93 11.3%
TSVT Stock Price vs. AI Score
Data gathered: December 9

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - 2Seventy Bio (TSVT)

Analysis generated September 26, 2024. Powered by Chat GPT.

2Seventy Bio is a biopharmaceutical company focused on advancing transformative gene therapy treatments for patients, particularly in oncology. The company emphasizes innovation in developing novel therapies aimed at addressing unmet medical needs. Emerging from the competitive biotech and pharmaceuticals sector, 2Seventy Bio has shown potential through its ongoing research and pipeline of products targeting critical areas in cancer treatment.

Read full AI stock Analysis

Stock Alerts - 2Seventy Bio (TSVT)

company logo 2Seventy Bio | December 9
Price is up by 6.5% in the last 24h.
company logo 2Seventy Bio | December 6
Price is up by 5.6% in the last 24h.
company logo 2Seventy Bio | December 5
Price is down by -5.5% in the last 24h.
company logo 2Seventy Bio | December 4
Price is down by -5% in the last 24h.

About 2Seventy Bio

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.


2Seventy Bio
Price $3.93
Target Price Sign up
Volume 302,750
Market Cap $182M
Year Range $3.11 - $5.63
Dividend Yield 0%
Analyst Rating 25% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2414M13M350,000-9.9M00.000
Q2 '249M15M-6.3M25M-19M0.450
Q1 '2412M16M-3.9M-53M-47M-1.010
Q4 '2311M17M-6.2M-57M-57M-1.110
Q3 '2312M34M-22M-72M-34M-1.000

Insider Transactions View All

Maus Marcela V. filed to sell 23,752 shares at $3.4.
November 20 '24
Snow Jessica filed to sell 156,330 shares at $4.3.
August 16 '24
Eatwell Victoria filed to sell 341,319 shares at $4.
August 7 '24
Eatwell Victoria filed to sell 341,332 shares at $4.
July 3 '24
Snow Jessica filed to sell 164,146 shares at $4.
July 3 '24

What is the Market Cap of 2Seventy Bio?

The Market Cap of 2Seventy Bio is $182M.

What is the current stock price of 2Seventy Bio?

Currently, the price of one share of 2Seventy Bio stock is $3.93.

How can I analyze the TSVT stock price chart for investment decisions?

The TSVT stock price chart above provides a comprehensive visual representation of 2Seventy Bio's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling 2Seventy Bio shares. Our platform offers an up-to-date TSVT stock price chart, along with technical data analysis and alternative data insights.

Does TSVT offer dividends to its shareholders?

As of our latest update, 2Seventy Bio (TSVT) does not offer dividends to its shareholders. Investors interested in 2Seventy Bio should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of 2Seventy Bio?

Some of the similar stocks of 2Seventy Bio are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.